Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

NCT05329532

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • Brighton and Sussex University Hospital Brighton, Default, United Kingdom
  • Velindre Cancer Centre Cardiff, Default, United Kingdom
  • Edinburgh Cancer Centre (NHS Lothian) Edinburgh, Default, United Kingdom
  • Royal Surrey NHS Foundation Guildford, Default, United Kingdom
View all 16 locations
View Trial Details
Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

NCT05107674

Conditions
Adenoma, Adnexal Diseases, Breast Diseases, +75 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NCT06682793

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Recruiting

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

NCT05919108

Conditions
Adenocarcinoma, Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, +13 more
Locations
  • Emory University/ Winship Cancer Institute Atlanta, Georgia, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
  • University of Texas, Southwestern Dallas, Texas, United States
View Trial Details
Recruiting

Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment

NCT06505018

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Triple-Negative Breast Carcinoma, +5 more
Locations
  • Institut de Cancérologie des Hauts-de-France (ICHF) Arras, France
  • Centre Hospitalier d'Auxerre Auxerre, France
  • Sainte Catherine - Institut du Cancer Avignon Provence Avignon, France
  • CH Aunay-Bayeux Bayeux, France
View all 51 locations
View Trial Details
Recruiting

Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel

NCT05582538

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Azienda Ospedaliero Universitaria Maggiore della Carità Novara, Italy
  • ASST Papa Giovanni XXIII Bergamo, Italy
  • Istituto Nazionale dei Tumori IRCCS Milan, Italy
  • IRCCS Istituto Nazionale Tumori "Fondazione Giovanni Pascale" Naples, Italy
View Trial Details

Related conditions